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OBJECTIVE: The purpose of this study was to determine
whether the Neuropathic Pain Symptom Inventory (NPSI)
adequately assesses neuropathic pain symptoms in patients with
diabetic peripheral neuropathy, post-herpetic neuralgia, trigemi-
nal neuralgia, and sciatica across multiple cultures. METHODS:
From data collected from 132 subjects in 6 countries, qualitative
research methods identiﬁed their most important symptoms (and
verbal descriptions) associated with neuropathic pain. A core set
of commonly described symptoms spanning multiple cultures
was also described. Moderators using a semi-structured discus-
sion guide conducted focus groups consisting of patients in the
US, Brazil, Japan, China, Finland, and Spain to elicit concepts
that were most important and relevant (concept elicitation
phase). Study subjects ranked the importance of each neuro-
pathic pain symptom, completed the NPSI, and commented on
its ability to capture key symptoms (face and content validation
phase). RESULTS: Descriptive terms for sensations of neuro-
pathic pain were similar in all countries; burning, electric shocks,
and pins and needles were among the most-common sensations.
Individuals with neuropathic pain experienced all sensations that
were included in the NPSI. They also tended to describe pins and
needles and numbness interchangeably, perhaps reﬂecting the
relative number of DPN subjects on study. Chinese subjects
tended to favor verbal descriptors and were more likely to relate
extreme pain with the heart because they believe the heart is the
most critical and sensitive part of the body. In Spain, the two
sensations of “pins and needles” and “stabbing” were occasion-
ally combined into one term as “stabbing pins on ﬁre”. CON-
CLUSION: This is the ﬁrst study to the knowledge of the authors
to conﬁrm such a “universality” of core neuropathic pain
descriptors across etiologies and cultures. Based on data from
these focus groups, the NPSI is an acceptable instrument for
assessing neuropathic pain worldwide.
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OBJECTIVE: To assess the psychometric properties of the
21-item Three-Factor Eating Questionnaire (TFEQ-R21) in
obese and non-obese subjects. METHODS: Data were obtained
from adults at baseline from a Phase 3 trial for a weight
management drug (n = 1739; mean body mass index [BMI]
[SD] = 38.6 [6.7]) and a web-based survey (n = 1275; non-obese
[BMI 18–27 kg/m2] and overweight and obese [BMI 27–76 kg/
m2]). Conﬁrmatory factor analyses (CFI) were undertaken to test
the TFEQ-R21 structure (Cognitive Restraint [CR], 6 items;
Uncontrolled Eating [UE], 9 items; Emotional Eating [EE], 6
items). Relationships between TFEQ domains and BMI were
evaluated. RESULTS: The clinical data indicated that the original
TFEQ-R21 structure needed reﬁnement. The original 21-item
model had 3 items removed from its CR domain. This resulted in
an 18-item TFEQ model (Bentler’s Comparative Fit Index
[CFI] = 0.91) that was otherwise identical to the original factor
structure (UE, CR, and EE). This modiﬁed structure was veriﬁed
using data from the web-based survey (CFI = 0.96). Cronbach’s
alphas for the 18-item TFEQ structure for each scale were high
and ranged from 0.70–0.92 and 0.78–0.94 in the clinical and
web-based studies, respectively. There were no ceiling or ﬂooring
effects. Correlations with BMI were small. In the clinical study,
the CR domain showed the most visibly linear relationship with
BMI; a one category increase led to a 1.55 kg/m2 (95% CI: 0.79;
2.30) decrease in BMI. In the web-based survey, there was a
visibly linear relationship between BMI and all domains except
the CR domain. The relationship between BMI and CR depended
in part on obese and diabetes status. CONCLUSION: The
18-item TFEQ (with 3 items removed from the TFEQ-R21 CR
domain) has satisfactory psychometric properties and may
be a useful tool to characterize uncontrolled eating, cognitive
restraint, and emotional eating in obese patients.
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OBJECTIVE: To determine the prevalence of nighttime pain
among patients with chronic painful conditions and its impact
on sleep quality. METHODS: Prospective study of 263 chronic
pain outpatients with musculoskeletal problems, arthritis/
rheumatism, headache, and sickle cell anemia who completed a
diary. Data included demographics, pain-related diagnosis, self-
reported pain scores (10-point scale), and resource utilization.
Patients completed Pittsburgh Sleep Quality Index (PSQI),
which includes questions about duration of sleep and sleep dis-
turbances in previous month, and yields a sleep quality score
ranging from 0 (best) to 21 (worst). Statistical tests used were
Kruskal-Wallis and Pearson’s correlation. RESULTS: Among
263 patients, the mean age was 50.6 (SD = 13.9) and 198 were
female (75%). Mean PSQI score was 12.1 (SD = 4.8) for
females, 11.7 (SD = 4.7) for males, and mean pain score was
5.3 (SD = 2.1). Patients disturbed by nighttime pain less than
once, once to twice, or 3 times per week had a mean PSQI of
8.3, 9.6, and 13.7, respectively, compared to 7.2 for patients’
sleep not disturbed by nighttime pain (p < 0.0001). Two-
hundred twenty-eight patients (86.6%) had trouble sleeping
because of pain at least once. Half of all patients were taking
sleep medications. Patients taking sleep medication less than
once, once to twice, or 3 times per week had mean PSQI of
10.2, 14.6, and 14.9, respectively, compared to 9.1 for patients
not taking any sleep medication (p < 0.0001). CONCLUSION:
Chronic pain patients may not routinely report nighttime pain
to providers, but our study conﬁrms that it is common and
indeed impairs sleep quality. Also, higher pain scores and
worse sleep quality were observed among those who re-
ported taking more sleep medications. Findings underscore
need to better manage pain by ensuring that patients’ pain
medications provide adequate analgesic coverage during sleep.
Doing so may reduce the need for sleep medications in this
population.
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